Cargando…

Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol

INTRODUCTION: Human papillomavirus (HPV) is a prevalent sexually transmitted infection linked to certain types of malignant neoplasms, notably cervical cancer (CC). In Kazakhstan, a high prevalence of high oncogenic HPV types (HR-HPV) has been observed, and CC ranks as the second most common maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassymbekova, Fatima, Zhetpisbayeva, Indira, Tcoy, Evgeniya, Dyussenov, Rassul, Davletov, Kairat, Rommel, Alexander, Glushkova, Natalya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533667/
https://www.ncbi.nlm.nih.gov/pubmed/37739465
http://dx.doi.org/10.1136/bmjopen-2023-074097
_version_ 1785112232503279616
author Kassymbekova, Fatima
Zhetpisbayeva, Indira
Tcoy, Evgeniya
Dyussenov, Rassul
Davletov, Kairat
Rommel, Alexander
Glushkova, Natalya
author_facet Kassymbekova, Fatima
Zhetpisbayeva, Indira
Tcoy, Evgeniya
Dyussenov, Rassul
Davletov, Kairat
Rommel, Alexander
Glushkova, Natalya
author_sort Kassymbekova, Fatima
collection PubMed
description INTRODUCTION: Human papillomavirus (HPV) is a prevalent sexually transmitted infection linked to certain types of malignant neoplasms, notably cervical cancer (CC). In Kazakhstan, a high prevalence of high oncogenic HPV types (HR-HPV) has been observed, and CC ranks as the second most common malignancy among women with a crude incidence rate of 18.3 cases per 100 000 women. The HPV vaccine, developed as the primary prevention measure against HPV infection, including the most prevalent HR-HPV, received approval from the WHO in 2009. In 2014, Kazakhstan initiated HPV vaccination as a pilot project in four sub-national regions; however, it was later in 2017 discontinued due to widespread parental refusal influenced by negative media reports. This study aims to examine knowledge, attitudes, information sources, barriers to HPV vaccination and factors associated with HPV vaccination hesitancy among different target groups in Kazakhstan prior to the HPV vaccine re-launch announced by the Ministry of Health. METHODS AND ANALYSIS: This mixed-method-designed research comprises quantitative and qualitative components. Data on HPV awareness, attitudes towards HPV vaccination and sources of information will be collected through an online survey administered by parents and legal guardians, health professionals, and schoolteachers in the Republic of Kazakhstan between January 2023 and January 2024. Additionally, qualitative data on Kazakhstani parental beliefs and attitudes toward HPV vaccination will be collected through online focus group discussions. ETHICS AND DISSEMINATION OF RESULTS: The study has been approved by the local ethics committee at the Kazakhstan Medical University “Higher School of Public Health” (KMU “KSPH”) (No. 138 of 31.05.2021). The results will be reported in publications, at conferences among researchers and healthcare and school education professionals in Kazakhstan, and internationally.
format Online
Article
Text
id pubmed-10533667
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105336672023-09-29 Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol Kassymbekova, Fatima Zhetpisbayeva, Indira Tcoy, Evgeniya Dyussenov, Rassul Davletov, Kairat Rommel, Alexander Glushkova, Natalya BMJ Open Public Health INTRODUCTION: Human papillomavirus (HPV) is a prevalent sexually transmitted infection linked to certain types of malignant neoplasms, notably cervical cancer (CC). In Kazakhstan, a high prevalence of high oncogenic HPV types (HR-HPV) has been observed, and CC ranks as the second most common malignancy among women with a crude incidence rate of 18.3 cases per 100 000 women. The HPV vaccine, developed as the primary prevention measure against HPV infection, including the most prevalent HR-HPV, received approval from the WHO in 2009. In 2014, Kazakhstan initiated HPV vaccination as a pilot project in four sub-national regions; however, it was later in 2017 discontinued due to widespread parental refusal influenced by negative media reports. This study aims to examine knowledge, attitudes, information sources, barriers to HPV vaccination and factors associated with HPV vaccination hesitancy among different target groups in Kazakhstan prior to the HPV vaccine re-launch announced by the Ministry of Health. METHODS AND ANALYSIS: This mixed-method-designed research comprises quantitative and qualitative components. Data on HPV awareness, attitudes towards HPV vaccination and sources of information will be collected through an online survey administered by parents and legal guardians, health professionals, and schoolteachers in the Republic of Kazakhstan between January 2023 and January 2024. Additionally, qualitative data on Kazakhstani parental beliefs and attitudes toward HPV vaccination will be collected through online focus group discussions. ETHICS AND DISSEMINATION OF RESULTS: The study has been approved by the local ethics committee at the Kazakhstan Medical University “Higher School of Public Health” (KMU “KSPH”) (No. 138 of 31.05.2021). The results will be reported in publications, at conferences among researchers and healthcare and school education professionals in Kazakhstan, and internationally. BMJ Publishing Group 2023-09-22 /pmc/articles/PMC10533667/ /pubmed/37739465 http://dx.doi.org/10.1136/bmjopen-2023-074097 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Kassymbekova, Fatima
Zhetpisbayeva, Indira
Tcoy, Evgeniya
Dyussenov, Rassul
Davletov, Kairat
Rommel, Alexander
Glushkova, Natalya
Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title_full Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title_fullStr Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title_full_unstemmed Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title_short Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: a mixed-methods study protocol
title_sort exploring hpv vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in kazakhstan: a mixed-methods study protocol
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533667/
https://www.ncbi.nlm.nih.gov/pubmed/37739465
http://dx.doi.org/10.1136/bmjopen-2023-074097
work_keys_str_mv AT kassymbekovafatima exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT zhetpisbayevaindira exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT tcoyevgeniya exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT dyussenovrassul exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT davletovkairat exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT rommelalexander exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol
AT glushkovanatalya exploringhpvvaccineknowledgeattitudesbarriersandinformationsourcesamongparentshealthprofessionalsandteachersinkazakhstanamixedmethodsstudyprotocol